Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: Role of the A subunit

Vaccine

Volumn 14, Issue 4, 1996, Pages 260-266

  De Haan, Lolke ^a   Holtrop, Marijke ^a   Verweij, Willem R ^a   Agsteribbe, Etienne ^a   Wilschut, Jan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

adjuvant; mucosal immunity; secretory IgA

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MOLECULAR CLONING; MOUSE; MUCOSA; NONHUMAN; NOSE LAVAGE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029865302     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00235-S     Document Type: Article

References (38)

1. Elson, C.O. and Ealding, W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 1984, 132, 2736-2741
2. Elson, E.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984, 133, 2892-2897
3. Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308
4. Wilson, A.D., Stokes, C.R. and Bourne, F.J. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins. Difference between mouse strains and protein antigens. Scand. J. Immunol. 1989, 29, 739-745
5. Walsh, E.E. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice. Vaccine 1993, 11, 1135-1138
6. Clements, L.D., Hartzog, N.M. and Lyon, F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988, 6, 269-277
7. Wilson, A.D., Clarke, C.J. and Stokes, C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immunol. 1990, 31, 443-451
8. Spangler, B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992, 56, 622-647
9. Lipscombe, M., Charles, I.G., Roberts, M., Dougan, G., Tite, J. and Fairweather, N.F. Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P69 antigen. Mol. Microbiol. 1991, 5, 1385-1392
10. Jagusztyn-Krynicka, E.K., Clark-Curtiss, J.E. and Curtiss, R. Escherichia coli heat-labile subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun. 1993, 61, 1004-1015
11. Dertzbaugh, M.T. and Elson, C.O. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 1993, 61, 48-55
12. Dertzbaugh, M.T. and Elson, C.O. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 1993, 61, 384-390
13. McKenzie, S.J. and Halsey, J.F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 1984, 133, 1818-1824
14. Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by a vaccine inoculated with cholera toxin B subunit. Vaccine 1988, 6, 409-415
15. Wu, W-Y. and Russell, M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 1993, 61, 314-322
16. Katz, L., Harmon, C.C., Buckner, G.P., Richardson, G.J., Russell, M.W. and Michalek, S.M. Protective salivary immunoglobulin A response against Streptococcus mutans antigen I/II coupled to the cholera toxin B subunit. Infect. Immun. 1993, 61, 1964-1971
17. Menge, A.C., Michalek, S.M., Russell, M.W. and Mestecky, J. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect. Immun. 1993, 61, 2162-2171
18. Tamura, S.I., Ito, Y., Asanuma, H. et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 1992, 149, 981-988
19. Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. and Holmgren, J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 1989, 57, 1072-1077
20. Tamura, S.-I., Yamanaka, A., Shimohara, M. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426
21. Tamura, S.-I., Asanuma, H., Tomita, T. et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083-1089
22. Lycke, N., Tsuji, T. and Holmgren, J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 1992, 22, 2277-2281
23. Wilson, A.D., Robinson, A., Irons, L. and Stokes, C.R. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally presented antigen. Vaccine 1993, 11, 113-118
24. Douce, G., Turcotte, C., Cropley, L. et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl Acad. Sci. USA 1995, 92, 1644-1648
25. Dallas, W.S., Gill, D.M. and Falkow, S. Cistrons encoding the Escherichia coli heat-labile toxin. J. Bacteriol. 1979, 139, 850-858
26. Vieira, J. and Messing, J. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 1982, 19, 259-268
27. Van der Linden, M.P.G., Mottl, H. and Keck, W. Cytoplasmic high level expression of a soluble, enzymatically active form of the Escherichia coli penicillin-binding protein 5 and purification by dye chromatography. Eur. J. Biochem. 1992, 204, 197-202
28. Meissner, P.S., Sisk, W.P. and Berman, M.L. Bacteriophage lambda cloning system for the construction of directional cDNA libraries. Proc. Natl Acad. Sci. USA 1987, 84, 4171-4175
29. Uesaka, Y., Otsuka, Y., Lin, Z. et al. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb. Path. 1994, 16, 71-76
30. Prank, S.E., Hofstra, W. Kingma, L. et al. Heat-labile enterotoxin of Escherichia coli. Characterisation of different crystal forms. J. Biol. Chem. 1987, 260, 13580-13584
31. De Haan, A., Geerligs, H.J., Huchshorn, J.P., Van Scharrenburg, G.J.M., Palache, A.M. and Wilschut, J. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 1995, 13, 155-162
32. De Haan, A., Renegar, K.B., Small, P.A. and Wilschut, J. Induction of a secretory IgA response in the murine urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. Vaccine 1995, 13, 613-616
33. McGhee, J.R., Mestecky, L., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
34. Grant, C.C.R., Messer, R.J. and Cieplak, W. Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin. Infect. Immun. 1994, 62, 4270-4278
35. Vadolas, L., Davies, L.K., Wright, P.J. and Strugnell, R.A. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 1995, 25, 969-975
36. Sanchez, J.L., Vasquez, B., Begue, R.E. et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 1994, 344, 1273-1276
37. Aitken, R. and Hirst, T.R. Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea. Vaccine 1993, 11, 227-233
38. Dickinson, B.L. and Clements, J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 1995, 63, 1617-1623